Mar 01, 2024
Individuals suffering from food allergies now have access to a medication that can potentially avert serious consequences. This medication, which has been available for twenty years, has received approval from the FDA. Xolair (omalizumab) by Roche and Novartis is the first food allergy treatment sanctioned to dimin...
Read More...
May 09, 2022
Food allergies are becoming a global concern. According to the World Allergy Organization, "food allergy impacted around 2.5% of the general population, but prevalence figures ranged from 1% to 10%." The increasing incidence of food allergies is raising food safety and public health issues and it is estimated that ...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
BYSANTI Approval Positions Vanda to Compete in the Antipsychotic Market
Mar 02, 2026
Newsletter/Whitepaper